ARTICLE | Company News
Avexa, Shire Pharmaceuticals Group plc deal
January 29, 2007 8:00 AM UTC
AVX received exclusive North American rights to commercialize SHP's apricitabine (SPD754) to treat HIV. In January 2005, AVX received exclusive global rights to develop and commercialize the compound ...